Fate Therapeutics Inc - ESG Rating & Company Profile powered by AI
Detailed Sustainability analysis of Fate Therapeutics Inc can be reached by signing in. If you are employed by Fate Therapeutics Inc and you would like to use your ESG aseessment, please contact us. Alternative companies in the rating peer group for Fate Therapeutics Inc are shown below.
Fate Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 4.6, social score of 5.0 and governance score of 8.0.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 563 | ReproCell Inc | 6.3 | High |
| 563 | Venus Remedies Ltd | 6.3 | High |
| 586 | Fate Therapeutics Inc | 6.2 | High |
| 586 | Althea Group Holdings Ltd | 6.2 | High |
| 586 | AlzeCure Pharma AB | 6.2 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Fate Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Fate Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Fate Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Fate Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Fate Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Fate Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Fate Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Fate Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Fate Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Fate Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Fate Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Fate Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Fate Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Fate Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Fate Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Fate Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Fate Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Fate Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.